Analysis | Medicare's Drug-Price Negotiations Can Get More Ambitious. Here's How

Next year, for the first time, Medicare will be allowed to start negotiating the prices of some prescription drugs.The policy is expected to lower out-of-pocket costs and save the US government almost $100 billion over a decade.It could prove one of the most valuable parts of the Inflation Reduction Act - but it isn't without flaws.

Read at Washington Post